openPR Logo
Press release

Key Insights of Future Prospects of Toxoplasmosis Testing Market During 2015-2021

Key Insights of Future Prospects of Toxoplasmosis Testing

The term toxoplasmosis refers to the infectious disease caused by the parasite Toxoplasma gondii. It may cause acute or chronic infection. Toxoplasmosis is caused by the consumption of improperly cooked mutton, pork, goat, or beef. It is also caused due to the transmission of T. gondii parasite through open wounds, contaminated raw meat, and food or dust contaminated with cat feces. These parasites are found in the kidney, bladder, and intestines of infected persons. In addition, it is transmitted by pregnant women to their developing fetuses through the placenta. The severity of toxoplasmosis depends upon the stage of pregnancy at which women acquires the infection. Infection results in premature birth or spontaneous abortion.

Toxoplasmosis exhibits mild symptoms such as swollen lymph nodes and discomfort. However, in individuals with HIV/AIDS, it results in severe, life threatening, and recurring symptoms. Toxoplasmosis can be serious or fatal in fetuses, newborns, and people with weakened immune systems. Serology, polymerase chain reaction, and immunoperoxidase stain are some of the tests used to diagnose toxoplasmosis. Serology is used to measure immunoglobulin G (IgG) in infected persons. Toxoplasmosis testing is a blood test used to check for the availability of antibodies for T. gondii. Hospitals, commercial or private laboratories, and physician offices are among the common users of toxoplasmosis testing.

Request Sample Report@ https://www.persistencemarketresearch.com/samples/4289

Currently, North America dominates the global toxoplasmosis testing market, followed by Europe. This is due to the rising prevalence of infectious diseases and increasing demand for effective testing methods by diagnostics laboratories in these regions. However, Asia is expected to be the fastest growing market in the next five years, due to the region’s developing healthcare infrastructure and increasing government initiatives for better healthcare facilities. Moreover, a large patient population base is also driving the growth of the toxoplasmosis testing market in this region.

Rising technological advancements in infection control instruments, an increasing number of anti-infective drugs, and the development of food sterilization and disinfection methods are among the key factors driving the growth of the global toxoplasmosis testing market. In addition, a rising birth rate and improving healthcare infrastructure in developing countries such as India, China and Brazil are also fuelling the growth of the global toxoplasmosis testing market. However, the lack of awareness among people about parasitic infections and economic downturn and saturation, and the high cost of toxoplasmosis tests are restraining the growth of the global toxoplasmosis testing market. In addition, stringent and time-consuming regulatory policies also impede the market’s growth.

Request TOC@ https://www.persistencemarketresearch.com/methodology/4289

Employment of single-use technology products and the availability of low-cost tests for toxoplasmosis could open up opportunities for new players in the global toxoplasmosis testing market. In addition, increasing focus on emerging markets such as India and China could also open up an opportunity for the market players in the global Toxoplasmosis testing market. Moreover, safety and quality of toxoplasmosis testing could be a challenge for the growth of the global toxoplasmosis testing market. A growing number of mergers and acquisitions is a recent trend in the global toxoplasmosis testing market. The major companies operating in this market are Abbott Laboratories, Affymetrix, Inc., Bio-Rad Laboratories, Inc., and Beckman Coulter, Inc. Other significant players are Biomerica, Inc., Cepheid, Inc., Biotest, and GenBio.

ABOUT US:
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance. To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

CONTACT:
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Key Insights of Future Prospects of Toxoplasmosis Testing Market During 2015-2021 here

News-ID: 1181809 • Views:

More Releases from Persistence Market Research

Frozen Foods Market Heats Up with Innovation and Growing Consumer Demand
Frozen Foods Market Heats Up with Innovation and Growing Consumer Demand
Market Overview: The frozen foods market consists of a wide range of products, including frozen fruits and vegetables, meat and seafood, ready-to-eat meals, and desserts. These products are preserved through freezing to maintain freshness and quality for an extended period. Market Size and Growth: The global market for frozen foods is forecasted to be of valuation US$ 281.0 Billion in the year 2022 which is expanding at a value CAGR of 5.1% and
The Global Graphene Market's Striking Growth and Innovative Applications
The Global Graphene Market's Striking Growth and Innovative Applications
Introduction Graphene, a single layer of carbon atoms arranged in a hexagonal lattice, has gained global recognition for its extraordinary properties, such as exceptional electrical and thermal conductivity, mechanical strength, and flexibility. Since its isolation in 2004 by Andre Geim and Konstantin Novoselov, graphene has sparked considerable interest in both scientific and industrial communities. This report explores the current state of the graphene market and its potential growth opportunities. Get Access To
Business Opportunities in Cyber Security Mesh Market : Top Countries Data Analysis, Emerging Trends with Upcoming Developments
Business Opportunities in Cyber Security Mesh Market : Top Countries Data Analys …
Market Overview: The projected global market size for cyber security mesh is expected to reach $8.8 billion by the year 2033, with an estimated valuation of $1.2 billion by 2023. This market is poised to experience a compound annual growth rate (CAGR) of 21.7% from 2023 to 2033. The global Cyber Security Mesh market is poised for significant growth as organizations worldwide grapple with the escalating threat landscape. Cybersecurity has become an
Synthetic Beta-Carotene Market To Boost Incredible Growth: 2033, Share Valuation and Industry Size
Synthetic Beta-Carotene Market To Boost Incredible Growth: 2033, Share Valuation …
Key market trends included a shift towards natural and plant-based ingredients, as consumers sought cleaner labels and healthier options. This drove the demand for naturally sourced beta-carotene, but synthetic beta-carotene still had its place due to its cost-effectiveness and consistency in production. The market was also influenced by regulatory changes and evolving dietary preferences, which affected the application and formulation of synthetic beta-carotene in various products. To obtain the latest market

All 5 Releases


More Releases for Toxoplasmosis

Technological Apogee To Catalyze The Toxoplasmosis Testing Market
Toxoplasmosis is an infection induced by Toxoplasma gondii parasite. Mostly cats serve as reservoir for this parasite. Based on the 2017 disease data from European Centre for Disease Prevention and Control, countries including Poland, United Kingdom and Germany had comparatively higher number of reported cases of congenital toxoplasmosis in infants creating a need for preventive measures to be taken for toxoplasmosis testing. This disease is transmitted through improper cooked meat consumption,
Toxoplasmosis Pipeline Review H1 2017
Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Toxoplasmosis - Pipeline Review, H1 2017, provides an overview of the Toxoplasmosis (Infectious Disease) pipeline landscape. Toxoplasmosis is a disease that results from infection with the Toxoplasma gondii parasite. Symptoms include body aches, swollen lymph nodes, headache, fever and fatigue. Risk factors include HIV/AIDS, chemotherapy and immunosuppressant drugs. Treatment includes an antimalarial drug and antibiotics. Get Sample Copy http://www.reportsweb.com/inquiry&RW0001858649/sample Report Highlights Publisher's Pharmaceutical and
Toxoplasmosis Testing Market Valuation By 2021
The term toxoplasmosis refers to the infectious disease caused by the parasite Toxoplasma gondii. It may cause acute or chronic infection. Toxoplasmosis is caused by the consumption of improperly cooked mutton, pork, goat, or beef. It is also caused due to the transmission of T. gondii parasite through open wounds, contaminated raw meat, and food or dust contaminated with cat feces. These parasites are found in the kidney, bladder, and
Toxoplasmosis Industry Assessment And Therapeutics Analysis Forecasts To 2017
Overview Toxoplasmosis is a disease that results from infection with the Toxoplasma gondii parasite. Symptoms include body aches, swollen lymph nodes, headache, fever and fatigue. Risk factors include HIV/AIDS, chemotherapy and immunosuppressant drugs. Treatment includes an antimalarial drug and antibiotics. Click here for sample report @ http://www.wiseguyreports.com/sample-request/2740059-toxoplasmosis-pipeline-review-h2-2017 Report Highlights The Pharmaceutical and Healthcare latest pipeline guide Toxoplasmosis - Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Toxoplasmosis (Infectious
Market Overview of Toxoplasmosis Research and Detailed Forecast 2018
Summary Toxoplasmosis is a disease that results from infection with the Toxoplasma gondii parasite. Symptoms include body aches, swollen lymph nodes, headache, fever and fatigue. Risk factors include HIV/AIDS, chemotherapy and immunosuppressant drugs. Treatment includes an antimalarial drug and antibiotics. GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/2740059-toxoplasmosis-pipeline-review-h2-2017 Report Highlights Pharmaceutical and Healthcare latest pipeline guide Toxoplasmosis - Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Toxoplasmosis (Infectious Disease), complete
Recent Research: Toxoplasmosis Testing Market Analysis to 2021
The term toxoplasmosis refers to the infectious disease caused by the parasite Toxoplasma gondii. It may cause acute or chronic infection. Toxoplasmosis is caused by the consumption of improperly cooked mutton, pork, goat, or beef. It is also caused due to the transmission of T. gondii parasite through open wounds, contaminated raw meat, and food or dust contaminated with cat feces. These parasites are found in the kidney, bladder, and